What is she best known for?
The fields of study she is best known for:
Özlem Türeci focuses on Antigen, Immunology, Cancer, Antibody and Immune system.
Her Antigen study integrates concerns from other disciplines, such as RNA, Molecular biology and Cytotoxic T cell.
Her Cancer research includes themes of Autoantibody, Cancer research, Melanoma and Blood test.
The various areas that Özlem Türeci examines in her Melanoma study include Cancer/testis antigens and Northern blot.
Immunogenicity is the focus of her Antibody research.
Her Vaccination research incorporates elements of CD8 and Immunity.
Her most cited work include:
- A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening (1112 citations)
- Human neoplasms elicit multiple specific immune responses in the autologous host. (1013 citations)
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer (914 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Cancer, Antigen, Cancer research, Immunology and Antibody.
Her Cancer study which covers Oncology that intersects with CA15-3, Pancreatic cancer and Ovarian cancer.
Her biological study spans a wide range of topics, including RNA, T cell, Immune system and Molecular biology.
Özlem Türeci works mostly in the field of Immune system, limiting it down to concerns involving Vaccination and, occasionally, Bioinformatics.
Her research integrates issues of Pathology, Tight junction, Claudin, Colorectal cancer and In vivo in her study of Cancer research.
Özlem Türeci studies Monoclonal antibody which is a part of Antibody.
She most often published in these fields:
- Cancer (33.66%)
- Antigen (31.19%)
- Cancer research (26.24%)
What were the highlights of her more recent work (between 2018-2021)?
- Cancer research (26.24%)
- Cancer (33.66%)
- Antibody (17.82%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Cancer research, Cancer, Antibody, Antigen and Immunotherapy.
Her work deals with themes such as Cell, Immune system, Claudin, Cytotoxic T cell and Chimeric antigen receptor, which intersect with Cancer research.
Her Immune system research is under the purview of Immunology.
Her Cancer study typically links adjacent topics like Melanoma.
Özlem Türeci combines subjects such as T cell, Severe acute respiratory syndrome coronavirus 2 and Virology, Vaccination with her study of Antibody.
Özlem Türeci focuses mostly in the field of Antigen, narrowing it down to topics relating to RNA and, in certain cases, Coronavirus disease 2019.
Between 2018 and 2021, her most popular works were:
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. (387 citations)
- Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. (341 citations)
- COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses. (246 citations)
In her most recent research, the most cited papers focused on:
Özlem Türeci spends much of her time researching Antibody, Vaccination, Immunology, RNA and Antigen.
Her Antibody research focuses on Virology and how it connects with Severe acute respiratory syndrome coronavirus 2 and Coronavirus disease 2019.
Her Vaccination research includes elements of T cell, CD8, Immune system, Immunization and Immunotherapy.
Her Immune system study combines topics in areas such as Cancer, Interim analysis and Melanoma.
Her Immunology study combines topics from a wide range of disciplines, such as Tolerability and Pandemic.
She has included themes like Cancer research and Tight junction in her RNA study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
